Biological stains are essential in the identification of physical, chemical and structural characteristics of biological content. The increasing use of stains in healthcare and life sciences research, the surge in the number of infectious diseases and increasing commercial use of stains are the factors responsible for the growth of the biological stains market.

Biological Stains Market: The growing research activities along with a rising expenditure on healthcare is projected to boost the market growth at a healthy CAGR of ~ 7.1 % during the forecast period from 2018 to 2023

Staining is a supplementary technique used to enhance the contrast in the microscopic image. Moreover, a growing number of diseases such as tuberculosis are contributing to the growth of the market. According to the Centers for Disease Control and Prevention (CDC), In the year 2016, more than 10.4 million tuberculosis patients were present in the world, and 1.7 million deaths occurred due to tuberculosis in the year 2016.

Some of the key players in the global biological stains market are Thermo Fisher Scientific Inc., Avantor, Becton, Dickinson and Company, Beckman Coulter, Inc., Merck KGaA, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc, Water Corporation, and bioMérieux SA.

Avail Sample Copy for This Report at: https://www.marketresearchfuture.com/sample_request/6462

Additionally, increasing R&D spending and aggressive strategies adopted by the top players, such as new product launches, and merger and acquisition activities are contributing to the growth of the market. The high costs associated with biological stains, availability of substitutes and risk of contamination due to the use of biological stains are likely to hinder the market growth during the forecast period.

For instance, in January 2017, Bio-Rad Laboratories announced the acquisition of RainDance Technologies for approximately USD  87 million. RainDance Technologies offers products such as microdroplet solutions for the early detection of cancer and other diseases.

The global biological stains market has been segmented on the basis of type, application, and end-user.

On the basis of type, the market has been classified as acid fuchsin, Congo red, crystal violet, eosin, methylene blue, iodine, safranin, and others. The eosin segment has been further divided into eosin Y, alcoholic eosin Y, eosin B, eosin- phloxine, and picro-eosin. The application segment has been further divided into histology, bacteriology, protein staining, gram staining, protein staining, DNA staining, and fluorescence microscopy.

The market, by end-user, has been segmented into diagnostic laboratories, academic and research institutes, pharmaceutical and biotechnology companies, and others.

Geographically global biological stains market has been segmented as Americas are likely to dominate the global biological stains market owing to the rising prevalence of infectious diseases, increasing use of stains in food testing, and the presence of a well-established healthcare system. According to the Centers for Disease Control and Prevention, in the US, approximately 16.8 million patients visited physicians for the treatment of infectious diseases in the year 2015.

The European market is expected to be the second-largest biological stains market. The market growth in this region can be attributed to the increasing number of academic and research institutes in the region and with-it rising demand for biological reagents for research and academic purpose. Moreover, awareness about diagnostics and increasing expenditure on diagnostics are contributing to the growth of the market in this region.

Brows Detailed Report at:  https://www.marketresearchfuture.com/reports/biological-stains-market-6462

Asia-Pacific is expected to be the fastest-growing biological stains during the forecast period owing to the increasing government support, rising investments in healthcare and the presence of well-established pharmaceutical market in the region. According to a report published by Australian Trade and Investment Commission, The Australian Government has spent more than USD 464.2 million on healthcare research and development in the year 2015.

The market in the Middle East & Africa is expected to account for the smallest share of the global biological stains market due to an underdeveloped healthcare sector and lack of technical knowledge.

The market growth in this region can be attributed to the rising expenditure for the healthcare sector and improving healthcare infrastructure. Avail Discount Enquiry for this Report.

About Market Research Future:

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Market Research Future

+1 646 845 9312

Email: [email protected]